Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.5K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.5K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unlocking Value: A Cost-Effectiveness Analysis of Hip PJI Diagnostic Pathways Employing the European Bone and Joint Infection Society/Musculoskeletal Infection Society Definition.

Arthroplasty today·2026
Same author

Indications for Use of Dual Mobility Demonstrate Significant Differences in Subsequent Instability.

The Journal of arthroplasty·2026
Same author

Phosphorus-31 Magnetic Resonance Spectroscopy for Serial Measurements of Cardiac Energetics During Temperature-Controlled Heart Preservation.

Journal of visualized experiments : JoVE·2026
Same author

Innate immune activation and mitochondrial ROS induce acute and persistent cardiac conduction system dysfunction after COVID-19.

JCI insight·2025
Same author

A highly effective, rodent model of complete heart block by epicardial radiofrequency ablation.

Scientific reports·2025
Same author

Diagnosis and Management of Osteonecrosis of the Femoral Head in Young Patients.

JBJS reviews·2025

Related Experiment Video

Updated: Dec 25, 2025

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection
08:52

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection

Published on: February 17, 2015

10.1K

Cellular Reprogramming Approaches to Engineer Cardiac Pacemakers.

Angel Xiao1, Hee Cheol Cho2,3

  • 1Emory University School of Medicine, 201 Dowman Dr, Atlanta, GA, 30322, USA.

Current Cardiology Reports
|April 2, 2020
PubMed
Summary
This summary is machine-generated.

Researchers are exploring biological pacemakers created by somatic reprogramming. This approach uses T-box 18 (TBX18) to convert cells into pacemaker-like cells, offering a potential alternative to electronic pacing devices.

Keywords:
Atrioventricular blockBiological pacemakerBradycardiaGene therapyInduced pacemaker myocytes

More Related Videos

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
10:05

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

9.0K
In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
05:04

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

3.7K

Related Experiment Videos

Last Updated: Dec 25, 2025

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection
08:52

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection

Published on: February 17, 2015

10.1K
Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
10:05

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

9.0K
In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
05:04

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

3.7K

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Molecular Cardiology

Background:

  • Pacemaker cells are crucial for regulating heart rhythm.
  • Electronic pacing devices are the current standard for treating heart block.
  • Understanding pacemaker cell function is key to developing novel therapies.

Purpose of the Study:

  • To review current knowledge on biological pacemakers generated through somatic reprogramming.
  • To explore the use of somatic reprogramming for mechanistic and metabolic insights into pacemaker cells.
  • To assess the potential of biological pacemakers as alternatives to electronic devices.

Main Methods:

  • Somatic reprogramming of cardiomyocytes using the embryonic transcription factor T-box 18 (TBX18).
  • Utilizing TBX18-induced pacemaker myocytes (iPMS) in various experimental models.
  • Investigating electromechanical, metabolic, and architectural properties of pacemaker cells.

Main Results:

  • Somatic reprogramming with TBX18 successfully converts cardiomyocytes into pacemaker-like cells.
  • TBX18-induced pacemaker myocytes (iPMS) show potential as a minimally invasive treatment for heart block.
  • Studies provide insights into the intricacies of cardiac pacemaker cell function.

Conclusions:

  • Biological pacemakers derived from somatic reprogramming hold promise for treating heart block.
  • TBX18-induced pacemaker myocytes (iPMS) represent a viable therapeutic avenue.
  • Further research is needed to overcome challenges for clinical translation.